CureApp
PrivateLast Round
Series G
Aug 16, 2022
Est. Valuation
$460M
Total Funding Raised
$109.93M
Company Overview
CureApp is a digital health company that develops evidence-based digital therapeutics (DTx) and mobile health programs to treat lifestyle-related diseases through personalized, app-based interventions.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Patient Engagement, Platform-as-a-Service, Healthcare Analytics
Business Model
B2B2C
Customer Profile
Usage-Based SaaS, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CureApp Comparables
Compare CureApp with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SUSMED, Inc. | 80% | |
| Click Therapeutics | 77% | |
| Otsuka Holdings | 76% |
CureApp Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series G | Aug 16, 2022 | ||||
| Series D | Mar 12, 2021 | ||||
| Series C | Jul 5, 2019 | ||||
| Series B | Feb 26, 2018 | ||||
| Series A | Feb 7, 2017 | ||||
Seed | Oct 6, 2015 |
CureApp Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Mori Trust Co., Ltd. | Series C |
| INTAGE HOLDINGS Inc. | Series C |
| Saisei Ventures | Series D |
| ITOCHU Technology Ventures | Series C, Series B, Series D |
| Shinsei Impact Investment Limited | Series D |
| Keio Innovation Initiative | Series C, Series A, Series B |
| Mizuho Capital | Series C, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 24, 2025
Launched DTx-BASE to help companies develop therapeutic apps.
- Aug 16, 2022
$52M round led by The Carlyle Group.
CureApp Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about CureApp's valuation, stock price, and market status.
Is CureApp a public or private company?
CureApp is a private company.
What is the current stock price of CureApp?
CureApp is a private company with no public stock price. No recent secondary market data is available.
How much is CureApp worth (valuation)?
Valuation information for CureApp is not publicly available.
Can I buy CureApp stock?
CureApp shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was CureApp's last funding round?
CureApp's most recent funding round was Series G on August 16, 2022.
Who are the main investors in CureApp?
Key investors in CureApp include Mori Trust Co., Ltd., Beyond Next Ventures, Iwagin Jigyo Souzou Capital Co.,Ltd..
Will CureApp IPO soon?
No public IPO plans have been announced for CureApp.
How can I track CureApp secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CureApp's secondary market activity and sign up for updates.